Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-20-022070
Filing Date
2020-11-20
Accepted
2020-11-20 11:32:22
Documents
35
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 form10q.htm 10-Q 626740
2 ex10-3.htm EX-10.3 68041
3 ex31-1.htm EX-31.1 10902
4 ex31-2.htm EX-31.2 10845
5 ex32-1.htm EX-32.1 5062
6 form10q_001.jpg GRAPHIC 4083
  Complete submission text file 0001493152-20-022070.txt   1918986

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE vapa-20200930.xml EX-101.INS 140591
8 XBRL SCHEMA FILE vapa-20200930.xsd EX-101.SCH 23079
9 XBRL CALCULATION FILE vapa-20200930_cal.xml EX-101.CAL 26677
10 XBRL DEFINITION FILE vapa-20200930_def.xml EX-101.DEF 76930
11 XBRL LABEL FILE vapa-20200930_lab.xml EX-101.LAB 170337
12 XBRL PRESENTATION FILE vapa-20200930_pre.xml EX-101.PRE 119553
Mailing Address 5550 NICOLLET AVENUE MINNEAPOLIS MN 55419
Business Address 5550 NICOLLET AVENUE MINNEAPOLIS MN 55419 612-812-2037
CQENS Technologies Inc. (Filer) CIK: 0001479915 (see all company filings)

EIN.: 271521364 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-55470 | Film No.: 201331317
SIC: 2834 Pharmaceutical Preparations